🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/07/2015 6,88 7,07 6,59 6,77 -1,60% 6,98% 643.000
06/07/2015 6,80 7,18 6,73 6,88 +0,58% 6,62% 835.400
02/07/2015 6,98 7,12 6,80 6,84 -1,58% 4,58% 657.600
01/07/2015 7,23 7,40 6,88 6,95 -2,80% 7,19% 1.034.200
30/06/2015 6,96 7,15 6,91 7,15 +3,62% 3,45% 862.300
29/06/2015 7,02 7,07 6,79 6,90 -3,23% 3,99% 1.524.600
26/06/2015 7,18 7,29 7,04 7,13 -0,90% 3,48% 1.533.200
25/06/2015 7,29 7,35 7,14 7,20 -0,76% 2,88% 776.000
24/06/2015 7,41 7,50 7,22 7,25 -2,55% 3,85% 1.288.700
23/06/2015 7,14 7,50 7,01 7,44 +4,20% 6,86% 1.754.200
22/06/2015 7,20 7,26 7,04 7,14 +0,14% 3,06% 1.066.400
19/06/2015 7,20 7,22 6,95 7,13 -0,70% 3,75% 1.089.700
18/06/2015 7,19 7,40 6,96 7,18 -0,28% 6,12% 2.501.200
17/06/2015 7,01 7,35 6,86 7,20 +7,62% 6,99% 3.184.700
16/06/2015 6,68 6,82 6,65 6,69 -0,74% 2,54% 369.300
15/06/2015 6,64 6,80 6,51 6,74 +0,30% 4,44% 854.400
12/06/2015 6,71 6,84 6,67 6,72 -0,88% 2,53% 726.600
11/06/2015 6,50 6,86 6,50 6,78 +3,67% 5,54% 1.162.700
10/06/2015 6,40 6,65 6,40 6,54 +2,19% 3,91% 1.115.200
09/06/2015 6,47 6,51 6,31 6,40 -1,84% 3,09% 706.500
08/06/2015 6,55 6,64 6,45 6,52 -0,61% 2,90% 741.000
05/06/2015 6,29 6,65 6,21 6,56 +3,96% 7,00% 999.500
04/06/2015 6,42 6,55 6,23 6,31 -1,79% 4,98% 517.200
03/06/2015 6,34 6,52 6,29 6,43 +1,34% 3,63% 782.700
02/06/2015 6,22 6,40 6,17 6,34 +2,09% 3,70% 662.200
01/06/2015 6,24 6,37 6,11 6,21 -1,43% 4,15% 730.700
29/05/2015 6,27 6,45 6,22 6,30 +0,80% 3,67% 1.101.000
28/05/2015 6,17 6,37 6,14 6,25 +0,64% 3,73% 736.600
27/05/2015 6,13 6,22 6,06 6,21 +1,47% 2,61% 712.100
26/05/2015 6,30 6,37 6,07 6,12 -2,24% 4,76% 831.000